Bridgeway Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bridgeway Capital Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-22,000	Closed	-$445K	–	1464
2017 Q2	$445K	Sell	22,000 -10,000	-31%	-$208K	0.01%	1125
2017 Q1	$861K	Hold	32,000	–	–	0.01%	868
2016 Q4	$609K	Sell	32,000 -7,000	-18%	-$134K	0.01%	1009
2016 Q3	$762K	Sell	39,000 -5,000	-11%	-$84.6K	0.01%	910
2016 Q2	$658K	Buy	+44,000	New	+$553K	0.01%	936
2015 Q3	–	Sell	-30,000	Closed	-$657K	–	1544
2015 Q2	$657K	Hold	30,000	–	–	0.01%	944
2015 Q1	$676K	Hold	30,000	–	–	0.01%	961
2014 Q4	$606K	Hold	30,000	–	–	0.01%	973
2014 Q3	$548K	Buy	+30,000	New	+$434K	0.01%	1023

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Bridgeway Capital Management's FLXN Position: Q3 2017 in Review

Bridgeway Capital Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2017, closing a stake of 22,000 shares — an estimated $445K sold.

Bridgeway Capital Management first reported a position in FLXN in Q3 2014 and held it in 9 quarters. The position peaked at $861K in Q1 2017. 116 funds tracked by Wall St. Rank hold FLXN as of Q3 2017.

Bridgeway Capital Management reported no remaining Flexion Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
Bridgeway Capital Management sold 22,000 Flexion Therapeutics, Inc. shares in Q3 2017, an estimated $445K.
Bridgeway Capital Management first reported a position in Flexion Therapeutics, Inc. in Q3 2014 and held it in 9 quarters.
Bridgeway Capital Management's Flexion Therapeutics, Inc. position peaked at $861K in Q1 2017.
116 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2017.

Based on Bridgeway Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.